Christopher Simon - 29 Aug 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: President & CEO, Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Issuer symbol: HAE
Transactions as of: 29 Aug 2024
Transactions value $: -$3,000,034
Form type: 4
Filing time: 03 Sep 2024, 16:20:34 UTC
Previous filing: 09 Aug 2024
Next filing: 19 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Other	-$3M	-39.7K	-10.95%	$75.56	323K	29 Aug 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 29, 2024, in an asset substitution transaction, Mr. Simon transferred 39,704 shares of the Issuer's common stock to the Simon Family Irrevocable Trust for the benefit of the reporting person's children, in exchange for cash in the amount of $3,000,034, with the number of shares determined by averaging the high and low sales prices of the Issuer's common stock as reported by the New York Stock Exchange on August 29, 2024. The substitution was made in accordance with the terms of the trust, which has an independent trustee.
F2	This number includes unvested restricted stock units previously reported.

Content

On August 29, 2024, in an asset substitution transaction, Mr. Simon transferred 39,704 shares of the Issuer's common stock to the Simon Family Irrevocable Trust for the benefit of the reporting person's children, in exchange for cash in the amount of $3,000,034, with the number of shares determined by averaging the high and low sales prices of the Issuer's common stock as reported by the New York Stock Exchange on August 29, 2024. The substitution was made in accordance with the terms of the trust, which has an independent trustee.

This number includes unvested restricted stock units previously reported.